(Q40383406)

20 September 2017

title

Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus (English)

1 reference

20 September 2017

1 reference

1 reference

1

1 reference

20 September 2017

Kiely P

2

1 reference

20 September 2017

Keller AJ

series ordinal

3

1 reference

20 September 2017

publication date

1 October 2005

1 reference

Internal Medicine Journal

20 September 2017

published in

1 reference

20 September 2017

volume

35

1 reference

20 September 2017

issue

10

1 reference

20 September 2017

page(s)

592-598

1 reference

Variant Creutzfeldt-Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00926.X

Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00926.X

International application of the incidence rate/window period model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00926.X

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00926.X

Sensitivity of HCV RNA and HIV RNA blood screening assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00926.X

The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00926.X

Results of viral marker screening of unpaid blood donations and probability of window period donations in 1997. EPFA Working Group on Quality Assurance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00926.X

New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00926.X

A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00926.X

Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00926.X

A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00926.X

Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00926.X

A method for estimating hepatitis B virus incidence rates in volunteer blood donors. National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00926.X

Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00926.X

Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00926.X

The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00926.X

A cost-effectiveness analysis of the use of a mechanical barrier system to reduce the risk of mistransfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00926.X

Don't bug me: the problem of bacterial contamination of blood components--challenges and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00926.X

Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00926.X

The UK blood transfusion service: over a (patent) barrel?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00926.X

10.1111/J.1445-5994.2005.00926.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference